zoledronic acid has been researched along with Paraganglioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Auernhammer, CJ; Bechmann, N; Beuschlein, F; Bihl, M; Bornstein, SR; Broglie Däppen, M; Eisenhofer, G; Fankhauser, M; Fassnacht, M; Friemel, J; Grossman, AB; Gulde, S; Hantel, C; Helm, J; Klink, B; Knösel, T; Kroiss, M; Ladurner, R; Lauseker, M; Lottspeich, C; Maurer, J; Nölting, S; Pacak, K; Pellegata, NS; Pietzsch, J; Reincke, M; Reul, A; Richter, S; Schober, L; Schütze, I; Spoettl, G; Ullrich, M; Vetter, D; Wang, K; Weber, A; Wenter, VUJ; William, D; Ziegler, CG | 1 |
1 other study(ies) available for zoledronic acid and Paraganglioma
Article | Year |
---|---|
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Everolimus; Humans; Mice; Paraganglioma; Pheochromocytoma; Zoledronic Acid | 2022 |